Jonathan Wygant

Jonathan Wygant is Chief Accounting Officer at Veracyte. He oversees all aspects of the company’s global accounting operations, financial reporting and tax functions.

Mr. Wygant has nearly 20 years of experience leading accounting operations for various healthcare and biotechnology companies. Prior to joining Veracyte in February 2022, he served as Corporate Controller at Biosplice Therapeutics, Inc., a clinical-stage biotechnology company, where he led all finance, accounting and reporting functions. Prior to that, Mr. Wygant was the Chief Financial Officer at Cibus Global, LLC., an agricultural biotechnology company. He also served as Vice President, Controller and Chief Accounting Officer at Alere, Inc., a $2.5B point-of-care diagnostics company that was acquired by Abbott. Prior to that, Mr. Wygant served as Senior Vice President, Controller and Chief Accounting Officer at CareFusion, a $3.5B global medical technology and manufacturing company that was acquired by BD (Becton, Dickinson and Company). Mr. Wygant began his career in accounting with PricewaterhouseCoopers.

Mr. Wygant holds a Bachelor of Accountancy from the University of San Diego.